| NCT06560632 | Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 | 2024-09-17 | 2028-12 | 2026-10 |
| NCT06232408 | LIONS (PLK4 Inhibitor in Advanced Solid Tumors) | ACTIVE_NOT_RECRUITING | PHASE1 | 2024-02-14 | 2025-10 | 2025-09 |
| NCT05147350 | Study of RP-6306 With FOLFIRI in Advanced Solid Tumors | TERMINATED | PHASE1 | 2022-08-09 | 2025-02-12 | 2025-02-12 |
| NCT05147272 | Study of RP-6306 With Gemcitabine in Advanced Solid Tumors | TERMINATED | PHASE1 | 2021-12-16 | 2024-08-28 | 2024-08-28 |
| NCT04972110 | Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2021-07-21 | 2025-12 | 2025-03 |
| NCT04855656 | Study of RP-6306 Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors | RECRUITING | PHASE1 | 2021-04-30 | 2026-12-31 | 2026-06-30 |
| NCT04497116 | Study of RP-3500, Camonsertib, in Advanced Solid Tumors | COMPLETED | PHASE1, PHASE2 | 2020-07-22 | 2025-06-13 | 2025-06-13 |